- E16.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E16.8 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E16.8 – other international versions of ICD-10 E16.8 may differ.
ICD-10-CM E16.8 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Increased secretion from endocrine pancreas of growth hormone-releasing hormone
- Increased secretion from endocrine pancreas of pancreatic polypeptide
- Increased secretion from endocrine pancreas of somatostatin
- Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E16.8:
- specified NEC > pancreatic internal secretion E16.9
- alpha > pancreatic islet cells E16.9
- growth hormone-releasing hormone > pancreas, endocrine E16.9
- pancreatic polypeptide > pancreas, endocrine E16.9
- somatostatin > pancreas, endocrine E16.9
- vasoactive-intestinal polypeptide > pancreas, endocrine E16.9